Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Ampk Activation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| TFEB nuclear translocation | activates | process | 0.90 |
| mitochondrial quality control | modulates | process | 0.90 |
| Tau Hyperphosphorylation | promotes | process | 0.90 |
| Cardiovascular Disease | protects_against | disease | 0.80 |
| Alzheimer's Disease | protects_against | disease | 0.75 |
| Amyotrophic Lateral Sclerosis | treats | disease | 0.75 |
| ischemic stroke | protects_against | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Low NAD+/NADH Ratio | causes | biomarker | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| AMPK Activation to Restore Autophagy and Clear α-Synuclein A | 0.559 | neurodegeneration | Does RGS6 upregulation or D2 autorecepto |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.772
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning Ampk Activation in their description or question text
No additional research found